These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 15659761)
21. Adaptation of yellow fever virus 17D to Vero cells is associated with mutations in structural and non-structural protein genes. Beasley DW; Morin M; Lamb AR; Hayman E; Watts DM; Lee CK; Trent DW; Monath TP Virus Res; 2013 Sep; 176(1-2):280-4. PubMed ID: 23602827 [TBL] [Abstract][Full Text] [Related]
22. Mutagenesis of the signal sequence of yellow fever virus prM protein: enhancement of signalase cleavage In vitro is lethal for virus production. Lee E; Stocks CE; Amberg SM; Rice CM; Lobigs M J Virol; 2000 Jan; 74(1):24-32. PubMed ID: 10590087 [TBL] [Abstract][Full Text] [Related]
23. The French neurotropic vaccine strain of yellow fever virus accumulates mutations slowly during passage in cell culture. Holbrook MR; Li L; Suderman MT; Wang H; Barrett AD Virus Res; 2000 Aug; 69(1):31-9. PubMed ID: 10989183 [TBL] [Abstract][Full Text] [Related]
24. Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses. Brandriss MW; Schlesinger JJ; Walsh EE; Briselli M J Gen Virol; 1986 Feb; 67 ( Pt 2)():229-34. PubMed ID: 3944585 [TBL] [Abstract][Full Text] [Related]
25. Replication of yellow fever virus in the mouse central nervous system: comparison of neuroadapted and non-neuroadapted virus and partial sequence analysis of the neuroadapted strain. Schlesinger JJ; Chapman S; Nestorowicz A; Rice CM; Ginocchio TE; Chambers TJ J Gen Virol; 1996 Jun; 77 ( Pt 6)():1277-85. PubMed ID: 8683217 [TBL] [Abstract][Full Text] [Related]
27. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates. Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852 [TBL] [Abstract][Full Text] [Related]
28. Interaction of yellow fever virus French neurotropic vaccine strain with monkey brain: characterization of monkey brain membrane receptor escape variants. Ni H; Ryman KD; Wang H; Saeed MF; Hull R; Wood D; Minor PD; Watowich SJ; Barrett AD J Virol; 2000 Mar; 74(6):2903-6. PubMed ID: 10684309 [TBL] [Abstract][Full Text] [Related]
29. Nucleotide sequence variation of the envelope protein gene identifies two distinct genotypes of yellow fever virus. Chang GJ; Cropp BC; Kinney RM; Trent DW; Gubler DJ J Virol; 1995 Sep; 69(9):5773-80. PubMed ID: 7637022 [TBL] [Abstract][Full Text] [Related]
30. Mutations in the E1 hydrophobic domain of rubella virus impair virus infectivity but not virus assembly. Qiu Z; Yao J; Cao H; Gillam S J Virol; 2000 Jul; 74(14):6637-42. PubMed ID: 10864678 [TBL] [Abstract][Full Text] [Related]
31. Mutagenesis of the N-linked glycosylation sites of the yellow fever virus NS1 protein: effects on virus replication and mouse neurovirulence. Muylaert IR; Chambers TJ; Galler R; Rice CM Virology; 1996 Aug; 222(1):159-68. PubMed ID: 8806496 [TBL] [Abstract][Full Text] [Related]
32. Mutagenesis analysis of T380R mutation in the envelope protein of yellow fever virus. Huang YJ; Nuckols JT; Horne KM; Vanlandingham D; Lobigs M; Higgs S Virol J; 2014 Mar; 11():60. PubMed ID: 24678844 [TBL] [Abstract][Full Text] [Related]
33. Comparison of the nucleotide and deduced amino acid sequences of the envelope protein genes of the wild-type French viscerotropic strain of yellow fever virus and the live vaccine strain, French neurotropic vaccine, derived from it. Jennings AD; Whitby JE; Minor PD; Barrett AD Virology; 1993 Feb; 192(2):692-5. PubMed ID: 8421909 [TBL] [Abstract][Full Text] [Related]
34. Attenuation of Murray Valley encephalitis virus by site-directed mutagenesis of the hinge and putative receptor-binding regions of the envelope protein. Hurrelbrink RJ; McMinn PC J Virol; 2001 Aug; 75(16):7692-702. PubMed ID: 11462041 [TBL] [Abstract][Full Text] [Related]
35. Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection Douam F; Soto Albrecht YE; Hrebikova G; Sadimin E; Davidson C; Kotenko SV; Ploss A mBio; 2017 Aug; 8(4):. PubMed ID: 28811340 [TBL] [Abstract][Full Text] [Related]
36. West Nile 25A virus infection of B-cell-deficient ((micro)MT) mice: characterization of neuroinvasiveness and pseudoreversion of the viral envelope protein. Chambers TJ; Droll DA; Walton AH; Schwartz J; Wold WSM; Nickells J J Gen Virol; 2008 Mar; 89(Pt 3):627-635. PubMed ID: 18272752 [TBL] [Abstract][Full Text] [Related]
37. Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone. Jiang X; Dalebout TJ; Lukashevich IS; Bredenbeek PJ; Franco D J Gen Virol; 2015 Apr; 96(Pt 4):804-814. PubMed ID: 25516543 [TBL] [Abstract][Full Text] [Related]
38. Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it. Hahn CS; Dalrymple JM; Strauss JH; Rice CM Proc Natl Acad Sci U S A; 1987 Apr; 84(7):2019-23. PubMed ID: 3470774 [TBL] [Abstract][Full Text] [Related]
39. A Polymorphism within the Internal Fusion Loop of the Ebola Virus Glycoprotein Modulates Host Cell Entry. Hoffmann M; Crone L; Dietzel E; Paijo J; González-Hernández M; Nehlmeier I; Kalinke U; Becker S; Pöhlmann S J Virol; 2017 May; 91(9):. PubMed ID: 28228590 [TBL] [Abstract][Full Text] [Related]
40. Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis. Jennings AD; Gibson CA; Miller BR; Mathews JH; Mitchell CJ; Roehrig JT; Wood DJ; Taffs F; Sil BK; Whitby SN J Infect Dis; 1994 Mar; 169(3):512-8. PubMed ID: 7908925 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]